Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults.

PHASE3CompletedINTERVENTIONAL

Enrollment

636

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

August 31, 2014

Conditions

HIV Infections

Interventions

DRUG

Efavirenz 600mg

3 x EFV 200 milligram (mg) tablets once daily

DRUG

Efavirenz 400mg

2 x EFV 200 milligram (mg) tablets plus 1x matched EFV placebo tablet once daily

Trial Locations (1)

St Vincent's Hospital, Sydney